Justera Health Ltd.
SCRSF · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -97.7% | -7.4% | -5.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 55.7% | 68.1% | 63.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $2 | $0 | $1 |
| SG&A Expenses | $0 | $2 | $0 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $2 | $0 | $1 |
| Operating Income | -$0 | -$2 | -$0 | -$0 |
| % Margin | -4,165.7% | -388.4% | -14.7% | -52.2% |
| Other Income/Exp. Net | $0 | -$2 | $0 | $0 |
| Pre-Tax Income | -$0 | -$3 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$3 | -$0 | -$0 |
| % Margin | -5,093.9% | -793.9% | -6.5% | -24.5% |
| EPS | -0.004 | -0.022 | -0 | -0.001 |
| % Growth | 81.5% | -10,700% | 75% | – |
| EPS Diluted | -0.004 | -0.022 | -0 | -0.001 |
| Weighted Avg Shares Out | 128 | 161 | 161 | 161 |
| Weighted Avg Shares Out Dil | 128 | 161 | 161 | 161 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$2 | -$0 | -$0 |
| % Margin | -3,902.6% | -380.5% | -6.6% | -44.7% |